Who owns Tenax Therapeutics?
- CUSIP Number: 88032l506
Tip: Access positions for across all investors
Analyze quarterly positions in Tenax Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tenax Therapeutics stock
Who bought or sold Tenax Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tucker Asset Management | 2.00 | $1.000000 | 0% | Dec 2023 |
|
Who sold out of Tenax Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| CI Private Wealth | Dec 2023 | 191k | $52k |
| Vanguard Group | Dec 2023 | 186k | $51k |
| Two Sigma Investments | Dec 2023 | 142k | $39k |
| Geode Capital Management | Sep 2023 | 119k | $35k |
| Citadel Advisors | Dec 2023 | 51k | $14k |
| BlackRock | Sep 2023 | 24k | $7.2k |
| Hrt Financial | Dec 2023 | 21k | $5.0k |
| LPL Financial | Sep 2023 | 20k | $6.0k |
| Tower Research Capital | Sep 2023 | 4.7k | $1.4k |
| Morgan Stanley | Sep 2023 | 675.00 | $202.027500 |
| Wells Fargo & Company | Dec 2023 | 184.00 | $51.004800 |
| Banque Cantonale Vaudoise | Dec 2023 | 50.00 | $0 |